StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3080% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Neuroone Medical Technologies operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Neuroone Medical Technologies's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.05M. For fiscal 2025 it was -$2.84M. The highest annual figure on record is -$5.09K in fiscal 2010.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$2.84M–
FY2024Sep 30, 2024-$11.01M–
FY2023Sep 30, 2023-$12.89M–
FY2022Sep 30, 2022-$7.52M–
FY2021Sep 30, 2021-$8.60M–
FY2020Sep 30, 2020-$3.43M–
FY2017Dec 31, 2017-$2.11M–
FY2016Dec 31, 2016-$21.11K–
FY2015Dec 31, 2015-$30.23K–
FY2014Dec 31, 2014-$26.17K–
FY2013Dec 31, 2013-$25.09K–
FY2012Dec 31, 2012-$13.73K–
FY2011Dec 31, 2011-$27.43K–
FY2010Dec 31, 2010-$5.09K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$1.08M–
Q2 FY2026CQ1 2026Mar 31, 2026-$1.33M–
Q1 FY2026CQ4 2025Dec 31, 2025-$3.12M-1597.6%
Q4 FY2025CQ3 2025Sep 30, 2025-$1.53M–
Q3 FY2025CQ2 2025Jun 30, 2025-$1.46M–
Q2 FY2025CQ1 2025Mar 31, 2025-$56.14K–
Q1 FY2025CQ4 2024Dec 31, 2024$208.05K–
Q4 FY2024CQ3 2024Sep 30, 2024-$2.67M–
Q3 FY2024CQ2 2024Jun 30, 2024-$2.36M–
Q2 FY2024CQ1 2024Mar 31, 2024-$2.18M–
Q1 FY2024CQ4 2023Dec 31, 2023-$3.81M–
Q4 FY2023CQ3 2023Sep 30, 2023-$2.90M-385.2%
Q3 FY2023CQ2 2023Jun 30, 2023-$2.94M–
Q2 FY2023CQ1 2023Mar 31, 2023-$3.55M–
Q1 FY2023CQ4 2022Dec 31, 2022-$3.49M–
Q4 FY2022CQ3 2022Sep 30, 2022$1.02M–
Q3 FY2022CQ2 2022Jun 30, 2022-$2.64M–
Q2 FY2022CQ1 2022Mar 31, 2022-$3.22M–
Q1 FY2022CQ4 2021Dec 31, 2021-$2.68M–
Q4 FY2021CQ3 2021Sep 30, 2021-$2.03M-844.2%
Q3 FY2021CQ2 2021Jun 30, 2021-$2.29M–
Q2 FY2021CQ1 2021Mar 31, 2021-$2.38M–
Q1 FY2021CQ4 2020Dec 31, 2020-$1.90M–
Q4 FY2020CQ3 2020Sep 30, 2020$272.67K–
Q3 FY2020CQ2 2020Jun 30, 2020-$1.22M–
Q2 FY2020CQ1 2020Mar 31, 2020-$1.25M–
Q1 FY2020CQ4 2019Dec 31, 2019-$1.22M–
Q4 FY2017CQ4 2017Dec 31, 2017-$598.40K–
Q3 FY2017CQ3 2017Sep 30, 2017-$596.50K–
Q2 FY2017CQ2 2017Jun 30, 2017-$562.25K–
Q1 FY2017CQ1 2017Mar 31, 2017-$350.92K–
Q4 FY2016CQ4 2016Dec 31, 2016-$7.33K–
Q3 FY2016CQ3 2016Sep 30, 2016-$5.57K–
Q2 FY2016CQ2 2016Jun 30, 2016-$8.21K–
Q1 FY2016CQ1 2016Mar 31, 2016$0–
Q4 FY2015CQ4 2015Dec 31, 2015-$6.35K–
Q3 FY2015CQ3 2015Sep 30, 2015-$3.25K–
Q2 FY2015CQ2 2015Jun 30, 2015-$1.03K–
Q1 FY2015CQ1 2015Mar 31, 2015-$19.59K–
Q4 FY2014CQ4 2014Dec 31, 2014-$9.03K–

More Neuroone Medical Technologies figures

See a number that looks wrong?